The Impact of RIPK1 Kinase Inhibition on Atherogenesis: A Genetic and a Pharmacological Approach.

导出 LinkOut

翻译打印收藏纠错

作者： Pauline,Puylaert ^[1] ; Isabelle,Coornaert ^[1] ; Cédric H G,Neutel ^[2] ; Yves,Dondelinger ^[3] ; Tom,Delanghe ^[4] ; Mathieu J M,Bertrand ^[3] ; Pieter-Jan,Guns ^[4] ; Guido R Y,De Meyer ^[3] ; Wim,Martinet ^[4]

作者单位： Laboratory of Physiopharmacology, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, University of Antwerp, Universiteitsplein 1, 2610 Antwerp, Belgium. ^[1] Laboratory of Physiopharmacology, Faculty of Medicine and Health Sciences, University of Antwerp, Universiteitsplein 1, 2610 Antwerp, Belgium. ^[2] VIB Center for Inflammation Research, 9052 Ghent, Belgium. ^[3] Department of Biomedical Molecular Biology, Ghent University, 9052 Ghent, Belgium. ^[4]

关键词 RIPK1 atherosclerosis necroptosis

DOI 10.3390/biomedicines10051016

PMID 35625752

发布时间 2022-07-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Biomedicines

2022年10卷5期

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

The Impact of RIPK1 Kinase Inhibition on Atherogenesis: A Genetic and a Pharmacological Approach.

Biomedicines

相似文献

Biomedicines

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

The Impact of RIPK1 Kinase Inhibition on Atherogenesis: A Genetic and a Pharmacological Approach.

Biomedicines

相似文献

Biomedicines

相关期刊

检索历史清除